Managing therapeutic competition in patients with heart failure, lower urinary tract symptoms and incontinence

Drugs & Aging
Cara Tannenbaum, Kristina Johnell

Abstract

Up to 50% of heart failure patients suffer from lower urinary tract symptoms. Urinary incontinence has been associated with worse functional status in patients with heart failure, occurring three times more frequently in patients with New York Heart Association Class III and IV symptoms compared with those with milder disease. The association between heart failure and urinary symptoms may be directly attributable to worsening heart failure pathophysiology; however, medications used to treat heart failure may also indirectly provoke or exacerbate urinary symptoms. This type of drug-disease interaction, in which the treatment for heart failure precipitates incontinence, and removal of medications to relieve incontinence worsens heart failure, can be termed therapeutic competition. The mechanisms by which heart failure medication such as diuretics, angiotensin-converting enzyme (ACE) inhibitors and β-blockers aggravate lower urinary tract symptoms are discussed. Initiation of a prescribing cascade, whereby antimuscarinic agents or β3-agonists are added to treat symptoms of urinary urgency and incontinence, is best avoided. Recommendations and practical tips are provided that outline more judicious management of heart failure patie...Continue Reading

References

Nov 1, 1991·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·M D Poole, D S Postma
Jun 1, 1990·The Journal of Urology·J E Casanova
Oct 29, 1997·Archives of Internal Medicine·T GravesM Weinberger
Jun 23, 2000·Obstetrics and Gynecology·L A AryaN D Jackson
Feb 20, 2002·JAMA : the Journal of the American Medical Association·JoAnne Micale FoodyHarlan M Krumholz
Feb 22, 2002·Neurourology and Urodynamics·Paul AbramsUNKNOWN Standardisation Sub-committee of the International Continence Society
Dec 24, 2002·Clinical Pharmacology and Therapeutics·Francesco LandiUNKNOWN Silvernet-HC Study Group
Jun 12, 2003·European Journal of Heart Failure·S P WrightR N Doughty
Sep 24, 2005·Journal of Aging and Health·Christine M RubyRichard C Bump
Aug 29, 2006·Heart Failure Reviews·Rachele AdorisioMihai Gheorghiade
Jun 28, 2007·The Annals of Pharmacotherapy·Kristina JohnellAndrejs Leimanis
Jul 17, 2007·Lancet·Louise MalletAllen Huang
Feb 13, 2008·Annals of Internal Medicine·Tatyana A ShamliyanTimothy J Wilt
Mar 4, 2008·Cardiology Clinics·Dhruv Kazi, Anita Deswal
Jun 28, 2008·Drugs & Aging·Peter TsakirisMartin C Michel
Aug 30, 2008·Archives of Gerontology and Geriatrics·O James EkundayoAli Ahmed
Feb 4, 2009·Journal of the American Geriatrics Society·Pearl G LeeCaroline Blaum
May 19, 2009·The Journal of Urology·Mary H PalmerJohn R Carlson
Oct 30, 2009·Current Urology Reports·O James Ekundayo
Oct 31, 2009·Journal of the American College of Cardiology·Filippos TriposkiadisJaved Butler
Nov 20, 2009·BJU International·Karl-Erik AnderssonAmit S Kulkarni
Dec 22, 2009·Neurourology and Urodynamics·Catherine E DuBeauUNKNOWN Fourth International Consultation on Incontinence
Jul 31, 2010·Journal of the American Geriatrics Society·Christine M RubyUNKNOWN Health, Aging and Body Composition Study
Oct 30, 2010·Journal of the American College of Cardiology·Jacob C JentzerAdrian F Hernandez
Nov 11, 2010·Current Treatment Options in Cardiovascular Medicine·Han-Na Kim, James L Januzzi
Jan 13, 2011·Age and Ageing·Jayna M Holroyd-LeducCara Tannenbaum
Feb 25, 2011·Urology Annals·Supatra LohsiriwatBansithi Chaiyaprasithi
Mar 23, 2011·The Journal of Urology·Ying H JuraFrancine Grodstein
May 21, 2011·British Journal of Clinical Pharmacology·Karl-Erik AnderssonBrian Olshansky
Sep 9, 2011·Archives of Gerontology and Geriatrics·Elizabeth A MadiganJennifer S Riggs
Dec 14, 2011·The Cochrane Database of Systematic Reviews·E Jean C Hay-SmithG Peter Herbison
Feb 18, 2012·The Cochrane Database of Systematic Reviews·Rajaa F FarisAndrew J S Coats
Mar 21, 2012·European Journal of Heart Failure·John J V McMurrayHenry Krum
Apr 20, 2012·The Cochrane Database of Systematic Reviews·Balraj S HeranJames M Wright
Apr 26, 2012·Neurourology and Urodynamics·Koji YoshimuraUNKNOWN Nagahama Cohort Research Group

❮ Previous
Next ❯

Citations

Sep 22, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Elvira Valera, Eliezer Masliah
Mar 24, 2016·Journal of the American Geriatrics Society·Christina E Reppas-RindlisbacherPaula A Rochon
Jul 6, 2016·The Canadian Journal of Cardiology·Dae Hyun Kim, Michael W Rich
Dec 30, 2016·International Journal of Clinical Practice·Qinghui MengMary H Palmer
Aug 8, 2015·British Journal of Community Nursing·Linda Nazarko
Oct 14, 2016·British Journal of Nursing : BJN·Alison Bardsley
Oct 7, 2017·Journal of the American Heart Association·Salim ShahChristopher S Wilcox
Jul 12, 2018·International Neurourology Journal·Youn-Jung Son, Bo Eun Kwon
Jan 5, 2020·International Urogynecology Journal·Sarunas P DaugirdasHolly Kramer
Oct 18, 2019·Therapeutic Advances in Drug Safety·Françoise Livio, Catia Marzolini
May 27, 2021·Journal of Medicinal Chemistry·Jinlong JiangAlexander Pasternak

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.